FDA Biosimilar Action Plan: could improving pharmacovigilance of biologics improve patient and physician confidence in biosimilars?
作者信息
Jordan John B, Christl Leah
机构信息
Global Regulatory and R&D Policy, Amgen Inc, Thousand Oaks, CA, USA.
出版信息
Expert Opin Drug Saf. 2020 Mar;19(3):229-232. doi: 10.1080/14740338.2020.1733966. Epub 2020 Mar 2.
Abstract
摘要
Zotero 插件